Natalya Volod'ko
TitleCited byYear
CMS physics technical design report: Addendum on high density QCD with heavy ions
D d'Enterria, M Ballintijn, M Bedjidian, D Hofman, O Kodolova, C Loizides, ...
Journal of Physics G: Nuclear and Particle Physics 34 (11), 2307, 2007
1732007
Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
M Lomnytska, A Dubrovska, U Hellman, N Volodko, S Souchelnytskyi
International journal of cancer 118 (2), 412-421, 2006
792006
TGFβ1/Smad3 counteracts BRCA1-dependent repair of DNA damage
A Dubrovska, T Kanamoto, M Lomnytska, CH Heldin, N Volodko, ...
Oncogene 24 (14), 2289, 2005
632005
Tumour-associated macrophages in breast cancer and their prognostic correlations
N Volodko, A Reiner, M Rudas, R Jakesz
The Breast 7 (2), 99-105, 1998
531998
Иммунологические механизмы естественной противоопухолевой резистентности [Immunological mechanisms of natural antitumor resistance]
БТ Билинский, НА Володько, ЯВ Шпарык
К.: Наукова думка, 1991
331991
Increased levels of the HER1 adaptor protein Ruk l /CIN85 contribute to breast cancer malignancy
A Samoylenko, B Vynnytska-Myronovska, N Byts, N Kozlova, O Basaraba, ...
Carcinogenesis 33 (10), 1976-1984, 2012
302012
Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma
O Mayevska, H Shuvayeva, N Igumentseva, S Havrylov, O Basaraba, ...
Інститут експериментальної патології, онкології і радіобіології ім. РЄ …, 2006
282006
Онкологія (підручник) [Oncology (textbook)]
БТ Білинський, ЮМ Стернюк, ЯВ Шпарик
Медицина світу, 1992
25*1992
Метастазування злоякісних пухлин: роль факторів пухлинного мікрооточення [Metastasis of cancer: the role of tumor microenvironment factors]
НА Володько
Львів: Медицина світу, 200 с., 2002
72002
Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers
S Souchelnytskyi, M Lomnytska, A Dubrovska, U Hellman, N Volodko
Proteomics 6 (S2), 65-68, 2006
62006
Evaluation of the peritoneal surface disease severity score (PSDSS) in ovarian cancer patients undergoing cytoreductive surgery and HIPEC: Two pathogenetic types based study
R Yarema, T Fetsych, N Volodko, M Оhorchak, O Petronchak, R Huley, ...
Journal of surgical oncology 117 (8), 1806-1812, 2018
42018
Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
L Knopfová, E Biglieri, N Volodko, M Masařík, M Hermanová, ...
Oncogene 37 (8), 1020-1030, 2017
42017
Shparyk YaV
BT Bylinskiy, NA Volod’ko
Immunologic mechanisms of natural antitumor resistance. Kyiv: Naukova Dumka, 1991
31991
Protein markers for the diagnosis and prognosis of ovarian and breast cancer
M Lomnytska, A Dubrovska, U Hellman, N Volodko, S Souchelnytskyi
US Patent 8,187,889, 2012
22012
Influence of IFN-alpha2b, TGFb1 and some chemotherapeutic agents on the proliferation of endothelial cells
NA Volod`ko, MI Lomnytska, S Souchelnytskyi, BT Bilynskyi
Experimental Oncology 25 (4), 252-255, 2003
2*2003
Metastasis of cancer: the role of tumor environment factors
NA Volodko
L’viv: Missioner, 2002
22002
Immunological mechanisms of natural antitumor resistance
BT Bilyns' kyi, NA Volod'ko, V Shparykh Ya
Kyiv: Naukova Dumka, 1991
21991
Complete cytoreduction for ovarian cancer: Is it enough for long‐term survival?
R Yarema, Т Fetsych, N Volodko, M Оhorchak, O Glehen
Journal of surgical oncology 118 (3), 593-594, 2018
12018
Современные аспекты диагностики и тактики ведения предопухолевой патологии шейки матки
ТФ Татарчук, НА Володько, НК Силина, ТН Силина, ИВ Гнатушок, ...
Репродуктивная медицина, 82-92, 2014
12014
Влияние ИФН-a2b, TФР-b1 и некоторых химиотерапевтических препаратов на пролиферацию эндотелиальных клеток
МИ Ломницкая, НA Володько, СИ Сушельницкий, БT Билинский
Эксперим онкология 25 (4), 252-5, 2003
12003
The system can't perform the operation now. Try again later.
Articles 1–20